Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries FibroBiologics, Inc. - Common Stock (NQ: FBLG ) 3.720 +0.150 (+4.20%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about FibroBiologics, Inc. - Common Stock FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology October 29, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024 October 28, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases October 18, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office October 16, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit October 11, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa September 30, 2024 Chief Scientific Officer, Hamid Khoja, Ph.D., to provide update on Psoriasis and Wound Care programs From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Engages Southern Star Research as CRO in Australia September 19, 2024 Southern Star Research will provide CRO services for FibroBiologics in Australia From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology September 12, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 06, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology August 20, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Files 2024 Second Quarter Report August 07, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics to Present at JonesTrading Healthcare Summit 2024 July 15, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology June 25, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Set to Join Russell 2000® Index June 13, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024 June 06, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Announces 2024 Annual Meeting of Stockholders May 15, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Files 2024 First Quarter Report May 14, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics to Present at the BIO International Convention 2024 May 07, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids April 25, 2024 Next-generation cell therapies to target chronic diseases From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA April 04, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus March 28, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics (NASDAQ: FBLG) Shares Jump 88% After Announcing Preclinical Data During Presentation at 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases February 13, 2024 FibroBiologics (NASDAQ: FBLG) shares caught a notable bid during trading on Tuesday, February 13, 2024. The clinical-stage biotech company saw Via Spotlight Growth Topics Intellectual Property Exposures Intellectual Property Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
